Sign in

Jane Shanahan

@janeshanahan.bsky.social
864 followers 654 following 175 posts

Snr Care Home Pharmacy Technician. Anticholinergics, polypharmacy, deprescribing. Speaker at The University of Lancashire #FindYourEvelyn pharmaceutical-journal.com/author/j…

PostsRepliesMedia
Reposted by Jane Shanahan
Alasdair MacLullich @amaclullich.bsky.social · 02/10/2026
"What would make this treatment worth it for you?" The answer is rarely the number we were planning to improve. More often it is getting to the toilet unaided, sleeping through, fewer hospital trips, being at a wedding in May.
Illustration of an older adult speaking with a younger adult across a table at equal eye level. The question reads: “What would make this treatment worthwhile for you?”
021
Reposted by Jane Shanahan
shibs @drshibley.bsky.social · 28/09/2026
Thanks to Journal of Dementia Care for publishing an article by me and Ming Ho on being a solo family carer. The link is here: journalofdementiacare.co.uk/issue/septem... I hope you enjoy it. It'll provide you an idea of what it's like to live well in a neighbourhood from a minority background.
023
Reposted by Jane Shanahan
The Lewy Body Society @lewybodysociety.bsky.social · 21/09/2026
The difficulty in diagnosing Lewy body dementia. #Dementia #Lewybodydementia
031
Reposted by Jane Shanahan
PrescQIPP CIC @prescqipp.info · 16/09/2026
On 23 September at 1pm - 2pm, our #PracticePlus webinar features two exceptional hosts who will speak with us about the practicalities of anticholinergic burden management in primary care. Register and find out more: ow.ly/QATQ50ZMq6l
011
Reposted by Jane Shanahan
APTUK @aptuk.bsky.social · 18/09/2026
📢 APTUK is delighted to launch our new Inclusion Practice Advisory Group, strengthening equity, diversity and inclusion across the pharmacy technician profession. Help shape a more inclusive future. Expressions of interest are open now. email: president@aptuk.org #APTUK #PharmacyTechnicians
012
Reposted by Jane Shanahan
Coeliac UK @coeliacuk.bsky.social · 17/09/2026
Coeliac disease is a serious autoimmune condition affecting 1 in 100 people in the UK, yet only 36% are diagnosed. Gluten triggers an immune response that damages the gut lining. Learn more: f.mtr.cool/8t7msr4x7e
052
Reposted by Jane Shanahan
Kevin Fong @drkevinfong.bsky.social · 17/09/2026
PUBLICATION DAY for #MinuteSix!!!!!!!! My toolkit for navigating the unknown. Super proud to finally have this out there. Took a loooong time. Thanks to all at @penguinrandomhouse.bsky.social who stuck by me & kept the faith. You can get it here. amzn.eu/d/06McPzcf
2226
Reposted by Jane Shanahan
Royal College of Pharmacy @rc-pharm.bsky.social · 14/09/2026
Our Repeat Prescribing Toolkit created in collaboration with the RCGP helps practices improve the consistency of repeat prescribing. It is the first national good practice guidance on repeat prescribing in 20 years. Find out more: ow.ly/q7q950ZNmGE
Royal College of Pharmacy
Repeat Prescribing Toolkit
022
Reposted by Jane Shanahan
Royal Osteoporosis Society @royalosteosoc.bsky.social · 13/09/2026
In our new series, Dr Zoe Williams will help explain what an osteoporosis diagnosis really means and what you can do to protect your bones. Early diagnosis can make a real difference. Check your risk for osteoporosis: thegreatbritishbonecheck.org.uk
youtube.com
Dr Zoe Williams: Know Your Osteoporosis Risk (Link in Description)
YouTube video by Royal Osteoporosis Society
012
Reposted by Jane Shanahan
Shaun Lintern @shaunlintern.bsky.social · 13/09/2026
🚨 Millions of elderly Britons take drugs known as anticholinergics - they can have serious side-effects and have been linked to a risk of dementia but patients aren't routinely warned. Another aspect of the polypharmacy crisis: www.thetimes.com/article/b5fb...
thetimes.com
Doctors prescribe drugs without mentioning dementia risk
Common medicines for diabetes, bladder control and depression can be associated with serious side-effects for older people
22914
Reposted by Jane Shanahan
deprescribing.org @deprescribing.bsky.social · 12/09/2026
Find our complimentary deprescribing.org tools and resources to reassess potentially inappropriate medications here: lnkd.in/ggwJhCCy
deprescribing.org
Deprescribing.org - Optimizing Medication Use
Deprescribing.org - reducing medications safely to meet life’s changes. Online resources for clinicians and patients to help with deprescribing.
021
Reposted by Jane Shanahan
deprescribing.org @deprescribing.bsky.social · 12/09/2026
We collaborated with an international team of experts to create a Prioritized List of 24 Potentially Inappropriate Prescribing Cascades published in @bmj.com: www.bmj.com/content/394/... This list will help inform future prescribing and deprescribing initiatives. Please reshare w/ your network!
184
Reposted by Jane Shanahan
Shaun Lintern @shaunlintern.bsky.social · 05/09/2026
🚨 EXC: An over-prescribing epidemic is sending 1,000 elderly patients to A&E every single day - a consequence of a fragmented NHS unprepared for the ageing silver tsunami heading its way as 468k baby boomers turn 80 this year: www.thetimes.com/article/ddf4...
thetimes.com
Mixing pills sends 1,000 elderly people a day to A&E
Our investigation shows millions are at risk of avoidable reactions to overprescribed drugs
105234
Reposted by Jane Shanahan
Healthcare Today @healthcaretoday.bsky.social · 25/08/2026
NICE referral criteria could fail to identify up to 95% of women under 50 who go on to develop breast cancer within ten years, researchers at the University of Cambridge and The Institute of Cancer Research have discovered. healthcaretoday.com/article/curr... #BreastCancer #CancerResearch
healthcaretoday.com
Current criteria may miss younger women at increased breast cancer risk
NICE referral criteria could fail to identify up to 95% of women under 50 who go on to develop breast cancer within ten years, researchers find.
001
Jane Shanahan @janeshanahan.bsky.social · 24/08/2026
1 in 3 women and 1 in 5 men will develop osteoporosis. howardluksmd.substack.com/p/6-exercise...
howardluksmd.substack.com
6 Exercises That Build Bone Density: Saturday Action Plan
Men, pay attention, you get osteoporosis, too.
000
Reposted by Jane Shanahan
shibs @drshibley.bsky.social · 23/08/2026
This is my piece about the problems with creating a flashy new policy for frailty and dementia. shibley.substack.com/p/why-did-my...
shibley.substack.com
Why did my mum stop liking desiccated coconut?
The incoming Modern Services Framework for frailty and dementia has made me worried about what design of NHS services has become about
022
Reposted by Jane Shanahan
APTUK @aptuk.bsky.social · 22/08/2026
Stepping Forward: Fellowship & Leadership 🗓️ 23 Sept | 7:30–8:30pm Hear from Claire Dearden, Aileen O’Hare & Olivia Musson as they share their fellowship journeys, leadership experiences & advice for pharmacy technicians. 🔗 Register: ow.ly/N5Uk50ZCLuu
A group of diverse pharmacy technicians join hands in a teamwork gesture, promoting the Association of Pharmacy Technicians UK's event titled 'Stepping Forward: Exploring Fellowship Opportunities and Leadership Development' scheduled online for September 23, 2026, emphasising connection, collaboration, support, and growth within the profession.
011
Reposted by Jane Shanahan
PrescQIPP CIC @prescqipp.info · 20/08/2026
Our next announced speaker for the 2026 PrescQIPP Awards is Professor Debi Bhattacharya! Find out more and register here: ow.ly/iAqN50ZsiTG #PatientSafety #Deprescribing #MedicinesOptimisation #BehaviourChange
011
Reposted by Jane Shanahan
CADeN | ReCAD @caden-recad.bsky.social · 18/08/2026
💊 “I took them like candy for 35 years.” At 81, Georges Marcoux, past Public Awareness Committee member, shares his journey away from decades of sleeping-pill use: cognitive behavioural therapy, new sleep habits, & supported deprescribing. Read his story here: tinyurl.com/mru32scy (French only)
232
Reposted by Jane Shanahan
British Geriatrics Society @gerisoc.bsky.social · 17/08/2026
We're getting ready for an autumn of events. Take a look at what's coming up and register your place: buff.ly/JUmzZWu
011
Reposted by Jane Shanahan
CPPE @cppeengland.bsky.social · 17/08/2026
We've extended our Leading for change programme from its previous format to a nine-month programme for non-PCPEP learners, giving give participants more opportunity to put learning into action. Apply now to begin on 1st September: 🔗https://ow.ly/Gaa850Zyu8N #LeadershipDevelopment #CPPE
011
Jane Shanahan @janeshanahan.bsky.social · 16/08/2026
Aug 2026 Higher #anticholinergic burden is associated with increased medium‐ and long‐term mortality following hip fracture bpspubs.onlinelibrary.wiley.com/doi/10.1002/...
bpspubs.onlinelibrary.wiley.com
BPS Publications
Aim Anticholinergic medications are frequently prescribed to older adults and are associated with adverse outcomes including cognitive impairment, delirium and mortality. In patients with hip fractu.....
001
Reposted by Jane Shanahan
PrescQIPP CIC @prescqipp.info · 12/08/2026
We're happy to present Lloyd Hambridge as a speaker at this year's PrescQIPP awards! Find out more and register here: ow.ly/U0WM50ZsiRQ #IntegratedCare #NeighbourhoodCare #PrimaryCare #HealthLeadership #PrescQIPP2026
022
Jane Shanahan @janeshanahan.bsky.social · 10/08/2026
Please take a moment to read the aim of this valuable research There is currently no standard approach to supporting people living with a dementia who are admitted to a mental health ward,especially where their carer/loved one is involved. Change is needed. #FINDME www.uwl.ac.uk/research/res...
uwl.ac.uk
Family Interventions In Dementia Mental Health Environments (FIND ME) Study | University of West London
The FIND ME study aims to understand what it’s like for carers when a person with dementia is admitted to a mental health ward.
020
Reposted by Jane Shanahan
safemedicine.bsky.social @safemedicine.bsky.social · 05/08/2026
Anticholinergic Drugs and Dementia Older adults advised to limit these drugs MHRA (UK Drug Regulator) advise that found “small increased risk of dementia cannot be ruled out” To take/use them with lowest possible dose, for shortest period of time needed www.medscape.com/viewarticle/...
medscape.com
Older Adults Advised to Limit Anticholinergic Medicines
The review examined 17 studies, all at serious or critical risk of bias, and could not confirm or exclude a causal link to dementia.
022
Reposted by Jane Shanahan
The Lewy Body Society @lewybodysociety.bsky.social · 05/08/2026
Did you catch Rachel Duffy's The One Show report tonight about the dementia awareness games we produced with the University of Liverpool? You may know Rachel as the winner of The Traitors. She is also a dementia advocate after her beloved mum died earlier this year of Parkinson's and dementia.
121
Reposted by Jane Shanahan
The Lewy Body Society @lewybodysociety.bsky.social · 05/08/2026
We are very proud she showcased our Dementia Inequalities Game and Dementia Explorer Game for children, as ways to help facilitate those conversations and better understanding about dementia. Order our dementia boardgames: www.lewybody.org/shop #lewybodydementia #TheOneShow #Dementia #TheTraitors
011
Reposted by Jane Shanahan
deprescribing.org @deprescribing.bsky.social · 04/08/2026
Find our resources to promote Shared-Decision Making here: buff.ly/rKtpTuv
buff.ly
Deprescribing in Ontario Long-Term Care - Deprescribing.org
A framework for helping discussions about deprescribing happen
011
Reposted by Jane Shanahan
deprescribing.org @deprescribing.bsky.social · 04/08/2026
🫵 Are YOU familiar with the "5 Tips to Manage Polypharmacy" Toolkit developed in collaboration between deprescribing.org, ISMP Canada, and Canada's Drug Agency? Our 1st Tip for Healthcare Providers: 1️⃣ "𝐃𝐨𝐜𝐮𝐦𝐞𝐧𝐭 𝐭𝐡𝐞 𝐑𝐞𝐚𝐬𝐨𝐧 𝐟𝐨𝐫 𝐔𝐬𝐞 𝐖𝐡𝐞𝐧 𝐏𝐫𝐞𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐚 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧" Learn more: buff.ly/ymPDevm
125
Reposted by Jane Shanahan
Alasdair MacLullich @amaclullich.bsky.social · 30/07/2026
Delirium has a visibility problem, not just a diagnostic one. How many cases of delirium are you missing day to day by not looking proactively?
022
Reposted by Jane Shanahan
The Pharmaceutical Journal @pharmaj.bsky.social · 29/07/2026
NHS England is looking to tender for a £360,000 contract to deliver clinical skills training for pharmacy technicians #ukpharmacy #pharmacytechnician
buff.ly
NHS England seeking provider for pharmacy technician clinical training
NHS England is looking to tender for a £360,000 contract to deliver clinical skills training for pharmacy technicians. On 20 July 2026, NHS England opened a tender that highlighted a need “to bridge…
022
Reposted by Jane Shanahan
Euan Reid @euanreid.pharmsky.app · 29/07/2026
New @mhragovuk.bsky.social assessment on bladder anticholinergics & dementia risk: Current evidence doesn't prove these medicines directly cause dementia, though a small risk can't be fully ruled out. #Pharmsky www.gov.uk/government/p...
gov.uk
Bladder Anticholinergics: review of risk of dementia
Public Assessment Report on the safety review of the available data on the risk of dementia with the use of bladder anticholinergic medicines.
022
Reposted by Jane Shanahan
The BMJ @bmj.com · 28/07/2026
Polymyalgia rheumatica is the most common inflammatory disease in patients of 50 and over. How is it diagnosed and why is this condition missed? #MedEd bit.ly/4vVDE4S
0116
Reposted by Jane Shanahan
CADeN | ReCAD @caden-recad.bsky.social · 28/07/2026
Some medications can make it harder to cope with extreme heat. 🌡 We're pleased to see Heal Canada adapt our evidence-informed article on medications & heat waves for the June issue of E3 Advocacy, helping this important information reach even more Canadians (pp. 108–112). 📚 tinyurl.com/4cbun8jf
145
Reposted by Jane Shanahan
Euan Reid @euanreid.pharmsky.app · 24/07/2026
BTS Sustainability Toolkit The Toolkit is designed to help healthcare professionals apply the principles of sustainability in both their services and the treatment of their patients. @btsrespiratory.bsky.social www.respiratoryfutures.org.uk/programmes-p...
respiratoryfutures.org.uk
BTS Sustainability Toolkit | Respiratory Futures
Tools, resources and ideas curated by the British Thoracic Society to make respiratory healthcare more sustainable.
042
Reposted by Jane Shanahan
deprescribing.org @deprescribing.bsky.social · 24/07/2026
Find helpful tools to reduce polypharmacy such as the "5 Tips to Manage Polypharmacy" resource below: buff.ly/5mowClK
cda-amc.ca
113
Reposted by Jane Shanahan
British Geriatrics Society @gerisoc.bsky.social · 19/07/2026
The Government’s 10 Year Health Plan for England goes big on the move to neighbourhood health. Our "Demystifying neighbourhoods" document outlines what neighbourhood working means in practice, how it differs from existing models, and what it could mean for older people’s care. buff.ly/LNZi8XZ
033
Reposted by Jane Shanahan
HappyHiker @happyhiker.bsky.social · 19/07/2026
Never underestimate how much water you need on a hard climb especially in hot weather. In this case walkers had to be rescued after running out of water on Scafell Pike in the #LakeDistrict. cumbriacrack.com/2026/07/16/w...
cumbriacrack.com
Walkers rescued after running out of water on Lake District mountain – cumbriacrack.com
042
Jane Shanahan @janeshanahan.bsky.social · 19/07/2026
#Anticholinergic meds with known cognitive risks remain widely used in care homes even among residents with dementia despite availability of safer alternatives.Findings identify clear targets for deprescribing initiatives. #FindYourEvelyn agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
agsjournals.onlinelibrary.wiley.com
Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing
Background Anticholinergic exposure is common in nursing homes; however, the true burden may be underestimated, particularly due to over-the-counter agents such as first-generation antihistamines th.....
011
Reposted by Jane Shanahan
Mark Hughes @markhughes1878.bsky.social · 17/07/2026
People living with Parkinson’s need their medication on time, every time. Yet too many doses are delayed or missed in hospital. Discover how a new dashboard is helping reduce avoidable harm, improve outcomes and support safer care. www.pslhub.org/learn/patien...
pslhub.org
The cost of a missed dose: how a new dashboard is transforming getting Parkinson’s medication on time
In this blog, Jean Almond and Sam Freeman Carney from Parkinson’s UK explain how their new time critical medication dashboard is exposing the cost of missed and delayed medication, encouraging…
121
Reposted by Jane Shanahan
Stephen Makin @stephenmakin.bsky.social · 16/07/2026
Anyone got a TIA clinic proforma i can steal?
001
Reposted by Jane Shanahan
The Pharmaceutical Journal @pharmaj.bsky.social · 16/07/2026
Stopping long-term antipsychotic treatment in people with dementia reduces the risk of fracture and hospitalisation for delirium, a study has found #ukpharmacy #dementia #antipsychotics
buff.ly
Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium
Stopping long-term antipsychotic treatment in people with dementia reduces the risk of fracture and hospitalisation for delirium, a study has found. The research, published in the latest issue of The…
032
Reposted by Jane Shanahan
Centre for Ageing Better @ageingbetter.bsky.social · 13/07/2026
Our Age-friendly Engagement Toolkit brings together guidance, case studies and templates to make it easier for local places to meaningfully involve older residents in decisions affecting their lives.
The most consistent message from older people about engagement is simple: tell us what you did with what we told you. Councils that close the feedback loop honestly, including when they cannot act on what they hear, and explaining why, build the trust that sustains participation over time.
132
Reposted by Jane Shanahan
Dementia Community @dementiacommunity.bsky.social · 13/07/2026
📢 Latest News! 👉UK Supreme Court judgement changes the definition of deprivation of liberty buff.ly/hEXS0Yj #dementia #News
021
Reposted by Jane Shanahan
Health Innovation Yorkshire & Humber @healthinnovyh.bsky.social · 13/07/2026
Many people feel AI is happening to them rather than with them. Join us tomorrow for an open, honest conversation about understanding AI, building trust and making sure communities have a voice in how technology is designed and used: onehealthtech.com/events-1/ai-...
onehealthtech.com
AI, Literacy & Trust: What Communities Need to Know | One HealthTech
OHT Leeds and Health Innovation Yorkshire & Humber
011
Reposted by Jane Shanahan
shibs @drshibley.bsky.social · 12/07/2026
Proposed contents of my book on neighbourhood health for frailty and dementia. www.linkedin.com/pulse/conten...
linkedin.com
Contents of my proposed book on neighbourhood health in frailty and dementia
Front matter and preface ~ 500 words Chapter 1 Why now? ~ 16000 words Establishes the book's critical-gerontology, care-ethics, and political-economy framework, explaining why neighbourhood health has...
021
Reposted by Jane Shanahan
Andy Conway Morris @andymoz78.bsky.social · 12/07/2026
Vaccines work, folks. Measles is an entirely preventable disease, it has no animal reservoir
098
Reposted by Jane Shanahan
Euan Reid @euanreid.pharmsky.app · 09/07/2026
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association #Pharmsky www.ahajournals.org/doi/10.1161/...
Polypharmacy in patients with cardiovascular disease occurs frequently across the age spectrum and can lead to inappropriate prescribing and adverse outcomes. Despite polypharmacy being a known problem for decades, there is limited guidance describing how to manage polypharmacy in patients with cardiovascular disease, including when and how to initiate deprescribing strategies. Although polypharmacy can occur at any age, studies often focus on older adults. The prevalence and consequences of polypharmacy, coupled with current gaps in the deprescribing literature, highlight the need for a scientific statement focused on deprescribing in all patients with cardiovascular disease. Deprescribing can improve outcomes and can apply to both cardiovascular and noncardiovascular drugs because both contribute to polypharmacy and poor outcomes associated with inappropriate prescribing in patients with cardiovascular disease. This scientific statement reviews the consequences of polypharmacy in patients with cardiovascular disease and provides tailored deprescribing strategies across the life span, with an emphasis on the unique considerations in pediatric, adult, and older adult populations. These strategies include observing clinical cues and triggers, using validated deprescribing tools, engaging in shared decision-making, and leveraging the roles of all members of the health care team to address barriers to deprescribing. Last, this scientific statement highlights current challenges related to polypharmacy and deprescribing and suggests some strategies to address them.
001